| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| HDFC Pharma and Healthcare Fund (G) Direct |
| [Equity: Sectoral] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
-0.57 |
| Equity |
97.25 |
| Trep |
3.32 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
33.14% |
| Top 10 Holdings |
54.11% |
| Top 25 Holdings |
90.68% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
70.19 |
| Healthcare |
27.06 |
| Cash |
2.75 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
6.28 |
| PE Ratio |
47.39 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Sun Pharmaceutical Industries Limited |
9.96 |
| DIVI LABORATORIES LTD |
7.16 |
| Max Healthcare Institute Limited |
5.57 |
| Lupin Limited |
5.26 |
| Cipla Limited |
5.19 |
| Aster DM Healthcare Limited |
5.05 |
| ACUTAAS CHEMICALS LIMITED |
4.58 |
| Alkem Laboratories Limited |
4.00 |
| Anthem Biosciences Limited |
3.81 |
| IPCA Laboratories Limited |
3.53 |
| TREPS - Tri-party Repo |
3.32 |
| Fortis Health Care Ltd |
3.18 |
| EQ- GLOBAL HEALTH LTD. |
3.08 |
| Krishna Inst of Medical Sciences Ltd. |
3.07 |
| Neuland Laboratories Limited |
2.93 |
| Glenmark Pharmaceuticals Limited |
2.88 |
| Vijaya Diagnostic Centre Limited |
2.53 |
| Shilpa Medicare Limited |
2.48 |
| Zydus Lifesciences Limited |
2.34 |
| Metropolis Healthcare Limited |
2.24 |
| Wockhardt Limited |
2.11 |
| Sai Life Sciences Limited |
1.71 |
| Rubicon Research Limited |
1.70 |
| Thyrocare Technologies Limited |
1.51 |
| Eris Lifesciences Limited |
1.49 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|